If you need help with NR 511 Week 3 Case Study Discussions and questions, our expert nursing writers are ready to answer your case study questions and discussions. We have a team of experienced and qualified nurses who can provide you with the help you need to get through your coursework.
We know how challenging it can be to keep up with the demands of nursing school, and we're here to help you succeed. Below are sample NR 511 Week 3 Case Study Discussions and questions we have answered accurately. Order your solutions now.
NR 511 Week 3 Case Study Discussions Part 1:
Concerning Part 1 of the assignment, you are in a patient scenario. Utiliz9ng the below information, provide answers the questions below:
- Briefly and clearly provide a summary of the H&P results as though you were presenting it to your preceptor utilizing the relevant facts from the present case. Apply shorthand usage where necessary as well as approved medical abbreviations when needed. Avoid irrelevant information and redundancy.
- Provide a differential diagnosis (plural) which might explain the patient’s chief complaint along with a brief statement of pathophysiology for each.
- Analyze the differential by using the pertinent findings from the history and physical to argue for or against a diagnosis. Rank the differential in order of most likely to least likely. (This is where you present your argument for EACH DIAGNOSIS in your differential using the patient’s subjective and objective information that was …).
- Identify any additional tests and/or procedures that you feel is necessary or needed to help you narrow your differential. All testing decisions must … supported with an EBM argument as to why it is necessary or pertinent in this case. If no testing is indicated or needed, you must also support this decision with EBM evidence. (This is where you identify, based on what you know thus far, test or test(s) that you would perform TODAY which would help you narrow your differential diagnosis).
*Do not list all of the possible tests that can … done. You are being evaluated on your diagnostic reasoning skills as well your ability to make decisions that are in-line with current practice recommendations. Just because a test is available does not mean it needs to … done.
NR 511 Week 3 Case Study Discussions Part 2
In Part 2 you might be … some additional history, exam or test findings. Using this information and the information in Part 1, answer the following questions:
- What is your primary diagnosis for this patient? Tell the reader how you came to this conclusion using the information that you were … (i.e., CXR result, lab result). Interpret the results into your diagnosis decision (i.e., tell how this information helped you to narrow your differential to the one diagnosis that you chose).
- Identify the corresponding ICD-10 Code for the diagnosis.
- Provide a treatment plan for this patient’s primary diagnosis which includes:
- a) Medication-all prescriptions and OTC medications should … written in RX format with an EBM to support:
- Medication Name & Medication Strength
- Dispensing quantity:
- Sig: …………..RF:
b) Any additional testing necessary for this particular diagnosis-typically done when you need more information to confirm a diagnosis or differentiate the diagnosis. Do not state all of the possibilities that are available. To assess your diagnostic reasoning skill, you will need to … decisive.
c) Patient education-self explanatory
d) Referral-self explanatory
e) F/U plan-include if and when the patient should follow-up *If part of the plan does not warrant an action, you must explain why. ALL medication and testing decisions (or decisions not to treat with medication or additional testing) MUST … supported with an EBM argument as you did in Part 1.
NR 511 Week 3 Case Study Discussions References
- Shulman, S., Bisno, A., Clegg, H., Gerber, M., Kaplan, E., Lee, G., Martin, J., & Van Beneden, C. (2012). Clinical Practice Guideline for the
- Diagnosis and Management of Group A Streptococcal Pharyngitis: A 2012 Update by Infectious Diseases Society of America. Clinical Infectious
- Disease, 55(10), e89. DOI: 10.1093/cid/cis629
